Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01017250 · ClinicalTrials.gov registry record · NA
Radiosurgery and Avastin for Recurrent Malignant Gliomas
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01017250 is a NA study that has completed, run by Duke University. The registered enrollment target is 15 participants.
The verdict
NCT01017250, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the central nervous system (CNS) toxicity in patients with recurrent malignant gliomas treated with concurrent Avastin and stereotactic radiosurgery (SRS).
Interventions
- DRUG Bevacizumab
- RADIATION Stereotactic Radiosurgery (SRS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01017250
The ClinicalTrials.gov registry entry for NCT01017250 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bevacizumab is the first listed.
NCT01017250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01017250 about?
NCT01017250 is a clinical study titled "Radiosurgery and Avastin for Recurrent Malignant Gliomas". The purpose of this study is to assess the central nervous system (CNS) toxicity in patients with recurrent malignant gliomas treated with concurrent Avastin and stereotactic radiosurgery (SRS).
What is the current status of trial NCT01017250?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2009-12. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01017250?
The interventions under investigation include: Bevacizumab (DRUG), Stereotactic Radiosurgery (SRS) (RADIATION).
Who is sponsoring clinical trial NCT01017250?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.